Newsfeeds - Spark Newswire

2 minute read

Guardant Health Presents Data Demonstrating Utility Of Comprehensive Genetic Profiling With Guardant360 Liquid Biopsy Test To Guide Treatment For Advanced Breast Cancer Patients At 2021 San Antonio Breast Cancer Symposium

Today, 4:29 PM

sGuardant Health, Inc. (NASDAQ:GH), a leading precision oncology company, today announced it will present new data demonstrating the benefits of using the Guardant360® liquid biopsy test to help guide targeted

5 minute read

Detecting Early Cancer Screening Stocks At An Early Stage Is Critical

By Gregory Bergman - CapitalWatch.com

Today, 4:29 PM

If you're going to get cancer, you’re going to want to detect it early. While we’ve come a long way, baby, when it comes to treating terrible maladies like lung cancer, the best treatment—and where the future of cancer treatment lies—is in early detection.

BMKDF

1 minute read

Guardant Health Registers 27% Revenue Growth In Q3, Tops Consensus; Backs FY21 Guidance

By Vandana Singh

Today, 4:29 PM

Guardant Health Inc (NASDAQ:GH) reported Q3 sales of $94.8 million, +27% Y/Y, beating the Wall Street estimate of $92.64 million.…

1 minute read

SVB Leerink Maintains Outperform on Guardant Health, Lowers Price Target to $170

By Benzinga Newsdesk

Today, 4:29 PM

SVB Leerink analyst Puneet Souda maintains Guardant Health (NASDAQ:GH) with a Outperform and lowers the price target from $180 to $170.

1 minute read

Guardant Health Q3 EPS $(0.70) Beats $(0.96) Estimate, Sales $94.78M Beat $92.64M Estimate

By Benzinga Newsdesk

Today, 4:29 PM

Guardant Health (NASDAQ:GH) reported quarterly losses of $(0.70) per share which beat the analyst consensus estimate of $(0.96) by 27.08 percent. This is a 10.26 percent increase over losses of $(0.78) per share from the

32 minute read

Earnings Scheduled For November 4, 2021

By Benzinga Insights

Today, 4:29 PM

Companies Reporting Before The Bell • DISH Network (NASDAQ:DISH) is likely to report quarterly earnings at $0.91 per share on revenue of $4.45 billion.

AAOI

7 minute read

The Week Ahead In Biotech (Oct. 31-Nov. 6): Earnings Pick Up Pace, Eton Awaits Seizure Drug Approval, Kidney Conference, More IPOs In The Pipeline

By Shanthi Rexaline

Today, 4:29 PM

Biotech stocks rose a third week running in the week ending Oct. 29 amid positive reaction to earnings. Big pharma earnings were mostly better than expected.

ADPT

2 minute read

Guardant Health Reports Initiation Of ORACLE Study To Evaluate Performance Of Co.’s Reveal Blood Test To Predict Recurrence Across Early-Stage Cancers

By Benzinga Newsdesk

Today, 4:29 PM

Guardant Health, Inc. (NASDAQ:GH), a leading precision oncology company, has initiated the Observation of ResiduAl Cancer with Liquid biopsy Evaluation (ORACLE) study, a 1,000-patient prospective, observational,

1 minute read

Guardant Health Will Not Go With NeoGenomics Deal: Bloomberg

By Vandana Singh

Today, 4:29 PM

Guardant Health Inc (NASDAQ:GH) has decided not to pursue a potential acquisition of NeoGenomics Inc (NASDAQ:NEO), Bloomberg reported citing people familiar with the…

5 minute read

54 Biggest Movers From Friday

By Lisa Levin

Today, 4:29 PM

Gainers

ADGI